SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785799.
  • 2
    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 17911798.
  • 3
    Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007: CD004659.
  • 4
    Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402414.
  • 5
    Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, Hyde C, Khan KS. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 2009; 88: 758765.
  • 6
    Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104: 13671391.
  • 7
    Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, Rey E. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 2010; 203: 383.e18.
  • 8
    Poon LC, Karagiannis G, Leal A, Romero XC, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks. Ultrasound Obstet Gynecol 2009; 34: 497502.
  • 9
    Thilaganathan B, Wormald B, Zanardini C, Sheldon J, Ralph E, Papageorghiou AT. Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia. Obstet Gynecol 2010; 115: 12331238.
  • 10
    Tuuli MG, Odibo AO. First- and second-trimester screening for preeclampsia and intrauterine growth restriction. Clin Lab Med 2010; 30: 727746.
  • 11
    Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn 2010; 30: 293308.
  • 12
    Broeze KA, Opmeer BC, van der Veen F, Bossuyt PM, Bhattacharya S, Mol BW. Individual patient data meta-analysis: a promising approach for evidence synthesis in reproductive medicine. Hum Reprod Update 2010; 16: 561567.
  • 13
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 20082012.
  • 14
    Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IXXIV.
  • 15
    Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6: 9.
  • 16
    Steyerberg EW. Clinical Prediction Models. A practical approach to development, validation and updating. Springer: New York, 2009.
  • 17
    Harrell FE Jr. Regression Modeling Strategies. Springer-Verlag: New York, 2001.
  • 18
    Twisk JWR. Software for multilevel analysis. In Applied Multilevel Analysis (Twisk JWR). Cambridge University Press : Cambridge, 2007; 146150.
  • 19
    Arenas J, Fernandez-Inarrea J, Rodriguez-Mon C, Dupla B, Diez E, Gonzalez-Garcia A. Doppler screening of the uterine arteries to predict complications during pregnancy. [Spanish]. Clinica e Investigacion en Ginecologia y Obstetricia 2003; 30: 178184.
  • 20
    Deurloo KL, Spreeuwenberg MD, Bolte AC, van Vugt JM. Color Doppler ultrasound of spiral artery blood flow for prediction of hypertensive disorders and intra uterine growth restriction: a longitudinal study. Prenat Diagn 2007; 27: 10111016.
  • 21
    Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2008; 102: 146151.
  • 22
    Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005; 46: 11231128.
  • 23
    Ohkuchi A, Minakami H, Sato I, Mori H, Nakano T, Tateno M. Predicting the risk of pre-eclampsia and a small-for-gestational-age infant by quantitative assessment of the diastolic notch in uterine artery flow velocity waveforms in unselected women. Ultrasound Obstet Gynecol 2000; 16: 171178.
  • 24
    Napolitano R, Santo S, D'Souza R, Bhide A, Thilaganathan B. Sensitivity of higher, lower and mean second-trimester uterine artery Doppler resistance indices in screening for pre-eclampsia. Ultrasound Obstet Gynecol 2010; 36: 573576.
  • 25
    Vollebregt KC, Gisolf J, Guelen I, Boer K, van Montfrans G, Wolf H. Limited accuracy of the hyperbaric index, ambulatory blood pressure and sphygmomanometry measurements in predicting gestational hypertension and preeclampsia. J Hypertens 2010; 28: 127134.
  • 26
    Rang S, van Montfrans GA, Wolf H. Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2008; 198: 519.e19.
  • 27
    Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther 2005; 20: 4853.
  • 28
    Singh T, Leslie K, Bhide A, D'Antonio F, Thilaganathan B. Role of second-trimester uterine artery Doppler in assessing stillbirth risk. Obstet Gynecol 2012; 119: 256261.
  • 29
    Khan KS, Bachmann LM, ter Riet G. Systematic reviews with individual patient data meta-analysis to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2003; 108: 121125.
  • 30
    Broeze KA, Opmeer BC, Bachmann LM, Broekmans FJ, Bossuyt PM, Coppus SF, Johnson NP, Khan KS, ter Riet G, van der Veen F, van Wely M, Mol BW. Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine. BMC Med Res Methodol 2009; 9: 22.
  • 31
    Individual Patient Data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine. http://www.studies-obsgyn.nl/IPD [Accessed 10 May 2012].
  • 32
    Senn S. Trying to be precise about vagueness. Stat Med 2007; 26: 14171430.
  • 33
    North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, Black MA, Taylor RS, Walker JJ, Baker PN, Kenny LC. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011; 342: d1875.
  • 34
    Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376: 631644.
  • 35
    James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol 2010; 221: 363378.
  • 36
    Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, Roberts TE, Mol BW, van der Post JA, Leeflang MM, Barton PM, Hyde CJ, Gupta JK, Khan KS. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008; 12: iiiiv, 1–270.
  • 37
    Shmueli A, Meiri H, Gonen R. Economic assessment of screening for pre-eclampsia. Prenat Diagn 2012; 32: 2938.